FDA approves NS Pharma's Duchenne drug on biomarker data, just like rival Sarepta

13th August 2020 Uncategorised 0

FDA approves NS Pharma’s Duchenne drug on biomarker data, just like rival Sarepta
aliu
Thu, 08/13/2020 – 09:27




More: FDA approves NS Pharma's Duchenne drug on biomarker data, just like rival Sarepta
Source: fierce